Learn from a comprehensive research conference presentation by Dr. Deborah Siegal, a distinguished Hematologist and Tier 2 Canada Research Chair, who addresses the critical medical decision-making process around restarting anticoagulation therapy following bleeding events. Explore the three fundamental questions of whether to restart anticoagulation, determining the optimal timing, and selecting the most appropriate methods for reinitiating treatment. Drawing from her extensive clinical experience at The Ottawa Hospital and research expertise as an Associate Scientist at the Ottawa Hospital Research Institute, Dr. Siegal provides evidence-based insights into this complex aspect of anticoagulation management in cardiovascular disease.